CPMV.US Mosaic Immunoengineering Inc

Healthcare Biotechnology USA Stocks
0.0600 USD
Close of Nov 11, 2026
0.0540 0.7460
Market cap
USD 435K
P/E
-
P/B
9.33x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CPMV.US undervalued?

Graham number

The Graham number of Mosaic Immunoengineering Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Mosaic Immunoengineering Inc fundamental analysis

No fundamental analysis for Mosaic Immunoengineering Inc yet.

Mosaic Immunoengineering Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Mosaic Immunoengineering Inc

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.

Full company profile